Authorising COVID-19 vaccines: MEPs to debate with European Medicines Agency


Your substances

None


Developing and deploying an effective and safe vaccine against the virus is likely to be the only way to end the pandemic. To this end, the Commission has proposed an EU vaccines strategy for COVID-19. The Commission has already entered into advance purchase agreements with several pharmaceutical laboratories in order to create a portfolio of potential vaccines against COVID-19. Any vaccine will need to be authorised by the European Medicines Agency in accordance with safety and efficacy standards.

CONTINUE READING ON www.europarl.europa.eu

                   

Related News

Loading...